
==== Front
Microbiol Spectr
Microbiol Spectr
spectrum
Microbiology Spectrum
2165-0497
American Society for Microbiology 1752 N St., N.W., Washington, DC

39101807
spectrum00817-24
10.1128/spectrum.00817-24
spectrum.00817-24
Research Article
environmental-microbiologyEnvironmental MicrobiologyOuter membrane vesicles of Acinetobacter baumannii DS002 carry circular DNA similar to bovine meat and milk factors (BMMFs) and SPHINX 2.36 and probably play a role in interdomain lateral gene transfer
Dhurve Ganeshwari 1
https://orcid.org/0009-0008-6235-0192
Behera Sandhya Rani 1
Kodetham Gopinath 2
https://orcid.org/0000-0002-9437-717X
Siddavattam Dayananda 1 sdsl@uohyd.ac.in, siddavattam@gmail.com

1 Department of Animal Biology, School of Life Sciences, University of Hyderabad , Hyderabad, Telangana, India
2 Department of Plant Sciences, School of Life Sciences, University of Hyderabad , Hyderabad, Telangana, India
Editor Ferraro Mariola J. University of Florida , Gainesville, Florida, USA

Address correspondence to Dayananda Siddavattam, sdsl@uohyd.ac.in, siddavattam@gmail.com
Present address: Department of Biochemistry, School of Sciences, GITAM University, Vishakhapatnam, Andhra Pradesh, India

The authors declare no conflict of interest.

9 2024
05 8 2024
05 8 2024
12 9 e00817-2402 4 2024
20 6 2024
Copyright © 2024 Dhurve et al.
2024
Dhurve et al.
https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

ABSTRACT

The discovery of Replication Competent Circular DNA molecules in mammalian cells and tissues is being linked to debilitating diseases, such as multiple sclerosis (MS), bovine spongiform encephalopathy (BSE), and colorectal cancer (CRC). These circular DNA molecules, otherwise known as bovine meat and milk factors (BMMFs) and Slow Progressive Hidden INfections of variable (X) latency (SPHINX), bear significant (80%) sequence similarity with the plasmids of Acinetobacter baumannii strains. Nanostructures, such as bacterial outer membrane vesicles (OMVs) serve as vehicles for transporting biomolecular cargo and have the potential to facilitate interkingdom lateral mobility of DNA. Strengthening the proposed hypothesis, this study demonstrates that OMVs derived from A. baumannii DS002 carrying four plasmids and genome (pTS236) of phage, AbDs1, successfully reached different parts of the body, including the central nervous system, following the injection of fluorescein isothiocyanate (FITC)-labeled OMVs into experimental mice. Out of the four OMV-associated plasmids, three (pTS4586, pTS9900, and pTS134338) were identified within the lumen, and the fourth one (pTS11291) was found on the surface of OMVs. In addition to the indigenous plasmids, the phage-encoded protein, Orf96, anchored on the surface of the OMVs by establishing a strong interaction with the OMV-associated porin, OmpA. Intriguingly, a subset of labeled OMVs, when incubated with Neuro2A cells, translocated across the membrane and reached to the cytoplasmic space of the cells. Collectively, the experimental evidence presented herein underscores the promising potential of OMVs as vehicles for delivering molecular cargo containing plasmids and phage genomes to diverse mammalian tissues and cells.

IMPORTANCE

Several independent studies have demonstrated the existence of replication competent circular DNA molecules of bacterial and viral origin in mammalian cells and tissues. However, studies about their origin and lateral mobility to mammalian cells are scarce. Our work describes the existence of circular DNA, similar to that of DNA molecules identified in mammalian cells, OMVs derived from soil isolate of A. baumannii DS002. Furthermore, the work also provides visual evidence that demonstrates the passage of labeled OMVs to different organs of experimental mice within hours after intravenously administering OMVs into experimental mice. Some of the labeled OMVs have even crossed the membrane of Neuro2A, suggesting the existence of interkingdom horizontal mobility between bacteria and mammals.

KEYWORDS

A. baumannii
outer membrane vesicles
OmpA
lateral gene transfer
bovine meat and milk factors
cover-dateSeptember 2024
==== Body
pmcINTRODUCTION

Recent studies have unveiled the presence of replication-competent circular DNA molecules akin to plasmid and phage genomes within various mammalian tissues and body fluids (1–3). These circular DNA entities, termed as SPHINX DNAs, shielded by nucleases, have been notably observed in abundant numbers within highly infectious cytoplasmic particles extracted from Creutzfeldt–Jakob Disease (CJD) and scrapie specimens (4). Subsequent investigations have unearthed SPHINX like DNA sequences in both milk and meat samples obtained from healthy cattle as well as from the tissues of patients afflicted with conditions, such as MS and CRC. Alongside these SPHINX like sequences, various other replication competent circular DNA molecules have been identified within these tissues (3, 5). Dubbed as BMMFs, these circular DNA structures exhibit chimeric characteristics, integrating both plasmid and viral DNA sequences. Notably, they have been found in substantial concentrations within CRC tissue (6, 7). BMMFs have been linked to chronic inflammation, DNA damage, and are suggested to function as indirect carcinogens (7–9). Further corroborating BMMFs pathogenic potential, the presence of SPHINX sequences has been shown to modify the expression profile of human embryonic kidney cells (HEK293TT) (10).

The genus Acinetobacter, known for its strict aerobic nature, thrives across diverse ecological niches by metabolizing a wide array of toxic and recalcitrant organic compounds (11). Among these, certain strains of A.baumannii pose a significant threat as opportunistic pathogens, primarily targeting critically ill patients (12–14). Notably, desiccation-resistant variants of A. baumannii persist longer in hospital environments by adhering to surfaces of healthcare settings (15–17). Furthermore, analysis of plasmid and phage genomes from A. baumannii has unveiled sequence similarities with SPHINX and BMMF sequences (2). For instance, the genome of Phage AbDs1, isolated from A. baumannii DS002, exhibited a 67% similarity with SPHINX 2.36 and 80% similarity with one of the BMMF sequences (2, 18). Such notable sequence congruence across diverse sources hints at the prevalence of interdomain horizontal gene transfer (HGT).

A. baumannii strains also survive on the body surface of animals, and their presence in soil, water, and surfaces of hospital environments provides enormous scope for HGT between these two inseparable entities (19–21). OMVs of A. baumannii carry macromolecules, such as proteins and nucleic acids (22–30). The nanosized bacterial OMVs are resistant to enzyme degradation and low pH (31) and release adhesion molecules, facilitating adherence of bacteria to host tissues (32–34). OMVs released from bacteria follow different pathways to reach the bloodstream, and from there, they gain access to various tissues and possibly cross the blood–brain barrier (BBB) to reach the brain (35–37). In this study, we show the association of indigenous plasmids and phage AbDs1 genome with OMVs isolated from A. baumannii DS002 and demonstrate that the OMVs labeled with fluorescent dye FITC reach various organs of mice. Our findings suggest that the OMVs of A. baumannii DS002 serve as a potential source of the replication of competent-circular DNA identified in mammalian tissues.

RESULTS

Several studies demonstrated instances of interdomain HGT involving bacteria and humans (19–21). The size of the human microbiome and its close association with somatic cells provides enormous scope for HGT between these two inseparable entities (20). OMVs secreted by bacteria carry macromolecules, such as proteins and DNA, and possess the remarkable capacity to traverse the BBB (35, 36, 38–42). A number of studies have convincingly established their role in the lateral mobility of bacterial DNA (43–45). In view of obvious sequence similarities between circular DNA molecules identified in mammalian tissues and Acinetobacter plasmids and phages, we have examined if OMVs isolated from A. baumannii DS002 have a role in delivering these extrachromosomal DNA molecules into mammalian cells.

OMVs contain indigenous plasmids

The pure OMVs isolated from A. baumannii DS002 cells were used for isolating total DNA (46). The procedure followed in the Methods section consistently yielded approximately 0.2 µg of DNA from 50 µg of OMVs. The isolated DNA was then sequenced, and the raw sequence reads were processed and assembled following standard protocols (11). These assembled sequences were then aligned with the genome sequence of strain DS002. Interestingly, all the assembled sequence contigs have matched only with four indigenous plasmids, pTS4586, pTS9900, pTS11291, and pTS134338 of A. baumannii DS002 (47). Notably, none of the contigs were aligned with the 37 kb plasmid pTS37365 identified in A. baumannii DS002. The sequence data were further validated by randomly amplifying the plasmid-specific sequences using pure OMVs as a template. In support of the sequence results, which indicated the selective exclusion of pTS37365 in OMVs, no pTS37365-specific sequences were amplified in PCR reactions (Fig. 1A). However, the amplicons specific to other four indigenous plasmids were obtained when PCR was performed using OMVs as template (Fig. 1A). The sizes of PCR amplicons coincided with the sizes of the corresponding regions of the indigenous plasmids pTS4586, pTS9900, pTS11291, and pTS134338 (Fig. 1A).

Fig 1 PCR amplification of plasmids associated with OMVs of A. baumannii DS002. A represents the amplification of DNA regions specific to indigenous plasmids of A.baumannii DS002. Lane 1 represents a kilobase ladder. Amplicons obtained when primers specific to pTS4586 (lane 2), pTS9900 (lane 3), pTS11291 (lane 4), pTS37365 (lane 5), and pTS134338 (lane 6) are shown in panel A. In lane 5 loaded with the reaction mix having primers specific to plasmid pTS37365, no amplification was observed, indicating the absence of plasmid pTS37365 in OMVs. B. Plasmid localization within OMVs: OMVs were treated with DNase to eliminate plasmid DNA present on the surface of the OMVs. The OMVs treated with DNase were used as template in the PCR reaction to detect plasmid present in the lumen. The amplicons obtained were then analyzed on 0.8% agarose gel along with the PCR amplicons obtained using DNase-untreated OMVs as a template. In all panels, lane 1 is the kilobase ladder, and lanes 2 and 3 represent PCR amplicons obtained when DNase untreated (−) and treated (+) OMVs were used as a template. The red arrow indicates amplicons obtained in DNase-treated OMVs. Indicating the presence of pTS11291 on the surface of OMVs, no amplification was noticed in the reaction mix with DNase-treated OMVs and primers specific to plasmid pTS11291. The amplicons specific to pTS4586, pTS9900, and pTS134338 were obtained, indicating their presence in the lumen of OMVs.

After ascertaining the presence of four indigenous plasmids, we designed further studies to establish their localization in OMVs. Initially, we have treated OMVs with DNase to eliminate any DNA associated with the surface of OMV. The DNase-treated OMVs were then used as templates in PCR reactions to amplify DNA corresponding to the four OMV-associated plasmids. Interestingly, we have obtained sequences specific to only plasmids pTS4586, pTS9900, and pTS134338 (Fig. 1B). There was no amplification in the reaction mix that contained pTS11291-specific primers, suggesting that the DNase treatment eliminated plasmid pTS11291 (Fig. 1B, panel III). DNase digestion failed to eliminate plasmids pTS4586, pTS9900, and pTS134338 as the membrane of OMVs prevented gaining access to these plasmids (Fig. 1B). We have performed these studies on two biological replicates, and in both cases, we have obtained identical results.

Phage AbDs1 is associated with OMVs

The experimental conditions used for the analysis of OMV DNA sequences did not reveal the presence of sequences specific to phage AbDs1 DNA (pTS236). The minimum cut off length (4 kb) of contigs used for aligning with the genome sequence of A. baumannii DS002 naturally eliminates inclusion of 2.36 kb phage genome from the sequence analysis. Our previous proteomic studies conducted to identify OMV-associated proteins (Proteome Exchange via PRIDE with the identifier PXD026751) revealed the presence of phage AbDs1-specific protein, when searched against pTS236 proteome (data not shown). This preliminary lead was verified by obtaining TEM images as well as Western blots. Initially, we treated the OMVs with Orf96-specific antibodies available in our laboratory (18) and obtained TEM images after incubating them with gold-labeled secondary antibodies. The TEM images showed the presence of gold-labeled secondary antibodies on the surface of OMVs (Fig. 2A), indicating the existence of phage AbDs1-specific protein, Orf96 on the surface of OMVs (Fig. 2Ai and ii ). Supporting the TEM images, the Western blots also revealed the presence of Orf96 in OMVs. However, the Orf96-specific signals obtained in the lanes loaded with total OMV proteins (Fig. 2B lane 2), affinity-purified Orf96 (Fig. 2B lane 3), and total soluble proteins of A. baumannii DS002 appeared in the form of a ladder (Fig. 2B lane 4), suggesting the formation of SDS resistant Orf96 multimers. Multimerization of SDS resistant protein is quite common, especially in virus-coded proteins (48). Since a similar trend is seen with respect of Orf96, we assume that Orf96 is a coat protein of AbDs1. After establishing the presence of phage AbDs1-specific Orf96 in OMVs, we have done PCR using pure OMVs as template to amplify ORFs identified in AbDs1 genome pTS236 (18). Intriguingly, amplicons corresponding to the size of two ORFs, orf96 (panel C-i), orf113 (panel C-ii) and the complete genome of AbDs1 (panel C-iii) were obtained, suggesting the presence of a complete genome of AbDs1 in OMVs.

Fig 2 Detection of phage AbDs1-specific Orf96 in OMVs. A (i) indicates a broad field used to take image showing the presence of gold particles around OMVs, A (ii) represents independent OMV showing the presence of gold particles around them. A (iii) shows TEM images of OMVs after treatment with only anti-Orf96 antibody. B (i) shows 12% SDS-PAGE. Lane 1 represents protein ladder, lane 2 is OMV proteome, lane 3 contains pure Orf96C6XHis protein and 4 shows total lysate of A. baumannii DS002. B (ii) corresponds to Western blot probed with polyclonal antibody specific to Orf96. C image indicates amplification of the phage genome using primers specific to different ORFs of phage AbDs1 genome (pTS236). C (i), (ii), and (iii) represent amplicons obtained for orf96, orf113, and complete genome (pTS236) of phage AbDs1 by using OMVs as templates, respectively.

Orf96 anchors to OMVs by interacting with OmpA

After establishing the presence of AbDs1-specific protein, Orf96, and its genome pTS236, further experiments were designed to elucidate the mechanism of anchoring of AbDs1-specific Orf96 with OMVs. Assuming that Orf96 is interacting with OMV-specific protein, we performed ligand blots to identify Orf96 interacting partner among OMV proteins. The affinity-purified Orf96C6XHis strongly interacted with a OMV protein of 37 kDa and contributed for a clear signal when the blot was probed with anti-His antibody (Fig. 3A). The peptide finger print pattern and the sequences of randomly obtained peptides of the 37 kDa protein band perfectly matched with outer membrane porin, OmpA (Fig. 3B).

Fig 3 Ligand blot assay for detection of OMV proteins interacting with phage genome-coded Orf96. A (i) shows 12.5% SDS-PAGE stained with Coomassie blue. Lane 1 represents protein ladder, lane 2 shows OMV protein, and lane 3 represents pure Orf96C6XHis used as positive controls. Unstained reference gel was used to transfer proteins onto the polyvinylidene difluoride (PVDF) membrane, and the blot was incubated with affinity-purified Orf96C6XHis . The blot was then probed with anti-His antibodies. A (ii) shows a clear signal detected below the size of 40 kDa marker protein in lane loaded with OMV proteins (lane 2), and the signal obtained with pure Orf96C6XHis (11 kDa) loaded as positive control is shown in lane 3. Mascot ID generated for 37 kDa protein band interacting with Orf96C6XHis has matched with OmpA and is shown in B. The sequences highlighted in red indicate the identity between the generated peptide sequences through MALDI TOF/TOF and the sequence of OmpA predicted from the genome sequence of A. baumannii ATCC 19606.

These results were further confirmed by performing reciprocal pulldowns by co-expressing OmpA and Orf96 with different affinity tags. The OmpA was expressed with a C-terminal FLAG tag, whereas Orf96 contained C-terminal His-tag. The Escherichia coli cell lysate containing these two proteins was used to perform pulldown assays using either nickel magnetic beads or magnetic beads tagged to anti-FLAG antibodies. The proteins purified using magnetic beads were then analyzed on SDS-PAGE, and Western blots were performed by using both anti-FLAG and anti-His antibodies to detect OmpACFLAG and Orf96C6XHis. When nickel magnetic beads were used to pulldown Orf96C6XHis, we have always seen co-elution of OmpACFLAG (Fig. 4A). In similar pulldown experiments performed using magnetic-FLAG tag antibodies along with OmpACFLAG, we have seen co-elution of Orf96C6XHis (Fig. 4B). These reciprocal pulldown assays clearly indicated interactions of phage AbDs1 protein Orf96 with OmpA.

Fig 4 Pulldown assays were performed to demonstrate interactions between Orf96 and OmpA. Pulldown assays performed using Ni-NTA and FLAG magnetic beads are shown in A and B, respectively. The cell lysates prepared from cells (pGD3+pT96W) co-expressing OmpACFLAG and Orf96C6His and separately (independent expression) were used to perform pulldown assays. CL represents cell lysate used as input. The FT, W, and E indicate flowthrough, wash, and elution fractions, respectively. A (i) indicates Western blots performed using anti-His antibodies. Similar experiments done using anti-FLAG antibodies are shown in A (ii). Lane CL contains both OmpACFLAG and Orf96C6His specific signals. A significant amount of OmpACFLAG is seen in lane FT. No signals were seen in lane W loaded with wash due to dilution of wash fraction. The OmpACFLAG co-eluted along with Orf96C6His is shown with a red arrow. The reciprocal pulldown shown in B indicates a similar loading and blotting pattern. The Orf96C6His co-eluted with OmpACFLAG is shown with the red arrow in B (ii).

OMVs cross the blood–brain barrier

Several independent studies have suggested OMVs crossing the BBB by using both paracellular and transcellular pathways (35–37). The OMV-associated proteins and enzymes modulate the permeability of cellular junctional complexes by cleaving the proteins associated with adherent junctions and tight junctions (39, 49). In light of these observations, we have conducted further experiments to examine if the OMVs of A. baumannii DS002 have any role in transporting the genome of phage AbDs1 and associating plasmids to various mammalian cells and tissues. In our initial experiments, we labeled OMV proteins with fluorescent dye FITC, and the labeled OMVs were intravenously injected into mice at the dosage of 5 µg, 20 µg and 30 µg. Mice injected with 30 µg of OMVs failed to survive. Therefore, the in vivo whole-body live images were obtained only for the animals injected with 5 µg and 20 µg OMVs, respectively. As seen in the images, the injected OMVs reached to various parts of the body, including the central nervous system (Fig. 5, panel A (ii) and panel B (ii)). They reached to the kidneys within 4 h (Fig. 5 panel A (i)) and were found in the circulatory system after 8 h (Fig. 5, panel A (ii)). The images obtained after 24 h have shown the presence of OMVs in spinal cords and even reached to the proximity of the brain in animals injected with 20 µg of OMVs (Fig. 5, panel B (ii)). After noticing the presence of OMVs in different organs of mice, we performed additional experiments to determine if they could be internalized into mammalian cells. The FITC-labeled OMVs were incubated with Neuro2A cell lines and visualized under the confocal microscope. Some of the OMVs successfully crossed the membrane of Neuro2A cells and emitted fluorescence light, indicating the internalization of OMVs within the Neuro2A cells (Fig. 6). Presumably, the translocated OMVs delivered associated plasmids and phage AbDs1 genome into animal cells.

Fig 5 Female BALB/c mice were intravenously administered with various concentrations of FITC-labeled outer membrane vesicles (OMVs), and the in vivo images were obtained in different anatomical planes, including coronal, sagittal, and trans-axial using in vivo imaging system (Perkin-Elmer IVIS Spectrum). A and B show images obtained for mice administered with 5 µg (A) and 20 µg (B) of FITC-labeled OMVs, respectively. Images obtained for mice after 4 h (A (i)) and 8 h (A (ii)) post-injection display the accumulation of OMVs in the kidney and circulatory system (highlighted by an arrow). In 24 h (A (iii)), the OMVs were detected in the spinal cord. B depicts mice injected with 20 µg of OMVs in 8 h post-injection, and the presence of fluorescence indicates OMV presence in the lymphoid system (B (i)) and in 24 h post-injection, some of them reached proximal to the brain (B (ii)). C represents images of the control group receiving sterile PBS, and fluorescence images obtained 24 h post-injection served as a baseline. These observations reveal distinct and time-dependent distribution patterns of systemically administered OMVs across various anatomical regions, including the kidney, circulatory system, spinal cord, lymphoid system, and brain vicinity.

Fig 6 Confocal microscopy pictures of Neuro2A cells taken at different fluorescence channels. Images were taken after incubation of the Neuro2A cells with FITC-labeled OMVs showing translocation of OMVs into Neuro2A cells. i (black and white channels) shows neuronal cells. ii shows nucleus stained with DAPI, and iii is OMVs labeled with FITC. iv is the merged image, indicating the presence of OMVs inside some of the Neuro2A cells.

DISCUSSION

Several independent studies have reported the presence of circular chimeric DNA in mammalian cells and tissues (50). Out of them, SPHINX DNA sequences identified in the brain samples of animals suffering from BSE and BMMFs, isolated from cattle milk and meat, acquire a lot of significance. The BMMF and SPHINX DNA sequences were selectively enriched in tissues of patients suffering from dreadful diseases, such as CRC, MS, and BSE (1, 2, 51). The BMMFs isolated to date are categorized into four distinct phylogenetic groups, such as BMMF-I, BMMF-II, BMMF-III, and BMMF-IV (2, 5). Of these four groups, three (BMMF-I to BMMF-III) share sequence similarities with the indigenous plasmids of A. baumannii. The fourth group (BMMF-IV) contains sequences similar to genome sequence of Gemycircularvirus (2). All of them have at least one ORF that codes for replication function and is highly conserved among all BMMFs and SPHINX sequences (52, 53). Interestingly, in human HEK293TT cells, the rep gene is expressed using transcriptional and translational machinery of host cells and supports its stable maintenance (10). In addition to the Rep protein, mass spectrometry analysis has shown the presence of BMMF-coded peptides in HEK293TT cells (10). Expression of these BMMF-coded peptides impacted the expression profile of host cells, especially those controlling cell cycle and cell viability (10). Although the direct link between the expression of BMMF-coded proteins and induction of diseases, such as MS, BSE, and CRC is lacking, the existence of antibodies in animal sera against the BMMF-coded proteins indirectly indicates their potential role in the induction of these diseases (2, 7).

OMVs play a key role in carrying the molecular cargo containing DNA and proteins from bacteria to mammalian cells and tissues (23, 54, 55). OMVs, which appear as spherical buds ranging from 20 to 400 nm contain enzymes, nucleic acids, metabolites, and toxins (32). The lipid bilayer of the OMV protects the biomolecular cargo from the harsh extracellular environments and safely transports them to distant places (31, 55). The OMVs released by pathogenic and commensal bacteria reach either gastrointestinal (GI) tract or directly to the blood stream. The OMVs released into GI tract cross the intestinal epithelium and vascular endothelium by following either paracellular or transcellular pathways to finally reach the blood stream (31). After reaching the blood stream, the OMVs travel to various organs and tissues and even cross the BBB to deliver macromolecules, such as DNA and other virulence factors, to various tissues, including the brain (37, 56–58).

Our previous studies have identified circular DNA molecule, pTS236, while analyzing plasmids of A. baumannii DS002 (18). The circular DNA molecule, pTS236, later identified as genome of phage, AbDs1, showed a significant sequence similarity with SPHINX 2.36 and class-II BMMFs, isolated from bovine meat and milk samples (2). Such high sequence similarities between DNA molecules isolated from taxonomically diverse sources suggest the existence of interdomain lateral gene transfer event. A. baumannii strains survive in a variety of ecological niches, including on the body surface of animals and plants. Some of them are opportunistic pathogens and contribute significantly to hospital-acquired infections (59). There is ample scope for the OMVs released by the free-living A. baumannii strains to reach the GI tract through the food chain and finally to the blood stream. Likewise, the pathogenic strains of A. baumannii directly deliver their OMVs into the blood stream. Once they reach the circulatory system, the OMVs successfully cross the BBB to reach the brain (35, 37). Corroborating with these studies, the labeled OMVs administered intravenously into mice have reached different organs and tissues of the mice (Fig. 5), and some of them even crossed the membrane of the cells to reach the cytoplasmic space (Fig. 6). Such a voyage of OMVs delivers associated DNA into the cells and also exposes its genome to the transcriptional and translational machinery of host cells. Some of the genes of OMV-associated DNA, particularly the rep gene, are expressed in eukaryotic cells (10). The expressed Rep protein has even contributed to the replication of circular DNA molecules in mammalian cells (10). These reports, if seen together with the conservation of rep genes among BMMFs and SPHINX, very well explain the molecular basis behind the existence of a large number of circular DNA molecules in mammalian cells. The data reported in this study provide conclusive evidence on the origin of circular DNA found in mammalian tissues and cells and highlight the role of OMVs in lateral mobility of bacterial DNA to mammalian cells.

MATERIALS AND METHODS

Bacterial strains and plasmids

Bacterial strains and plasmids used in this study are listed in supplementary table (Table S1). The E. coli and A. baumannii DS002 cultures were grown in LB medium at 37°C and 30°C, respectively. When necessary, antibiotics chloramphenicol (30 µg/mL) and streptomycin (20 µg/mL) were supplemented to the culture medium.

Isolation of total DNA from OMVs

The OMVs of A. baumannii DS002 were isolated following established procedures described elsewhere (46). The purified OMVs (50 µg of protein concentration) were initially adjusted to 2% Triton X-100 concentration by adding the necessary volume of a stock solution. This mixture was then thoroughly blended and incubated at 55°C for 10 min to solubilize the membrane of OMVs. The Triton X-100 treated OMVs were then used to isolate total DNA by using QIAGEN Genomic-tip Kit following the manufacturer’s protocols. Briefly, the lysate of OMVs was mixed with an equal volume of binding buffer and loaded onto the QIAGEN genomic DNA extraction column. Subsequently, the column was washed twice with a wash buffer and the DNA bound to the column was eluted with 20 µL of sterile water. While isolating DNA present inside the lumen, the OMVs were incubated with 2 Units of DNase for 30 min at 37°C to eliminate surface-associated DNA. Subsequently, the DNase was inactivated by incubating OMVs at 80°C for 10 min. Following DNase treatment, the OMVs were used to isolate DNA present within the lumen of OMVs, following the procedures described above.

Detection of plasmids and phage AbDs1 in OMVs

Our previous studies have reported the complete genome sequence of A. baumannii DS002. In addition to the 3,430,798 bp long chromosome, A. baumannii DS002 contains five indigenous plasmids and phage AbDs1 genome (11). The DNase treated and untreated OMVs were used as a source of template, and PCR was performed using primers specific to indigenous plasmids and phage AbDs1 DNA (Table S2). If plasmid-specific amplicons were obtained both in DNase treated and untreated OMVs, they were considered as present in the lumen. If the amplicons were seen only in DNase-untreated OMVs they were assumed as present on the surface of the OMV.

Detection of phage AbDs1-specific proteins in OMVs

The presence of phage AbDs1 genome-coded proteins in OMVs of A. baumannii was determined by performing both Western blots and immunogold labeling techniques. Initially, OMV proteins equivalent to 30 µg were separated on 12% SDS gel, and Western blots were performed using antibodies specific to one of the phage AbDs1 genome-coded protein, Orf96 (18). Because Western blots indicated the presence of phage AbDs1-coded protein, Orf96 in OMVs, TEM images were obtained to establish its precise location in OMVs. Initially, the OMVs were treated with Orf96-specific primary and gold-labeled secondary antibodies, and TEM images of OMVs were taken following procedures described elsewhere (46). Briefly, different concentrations of purified OMVs were spotted onto copper grids and rinsed them by floating on a droplet of distilled water before incubating in a blocking buffer (0.3% BSA in PBS) for 15 to 30 min. Then, the grids were thoroughly washed with a wash buffer (0.03% BSA in PBS) and were incubated with anti-Orf96 antibodies for 2 h. Subsequently, the grids were washed extensively to remove excess antibodies and carefully submerged in a droplet of buffer containing gold-conjugated secondary antibodies for 1 h. After incubation, the grids were washed three times each with the wash buffer and water. Excess liquid was removed by gently touching the grids with filter paper. Finally, the grids were stained with 2% uranyl acetate for 1 min before obtaining images using a transmission electron microscope (TEM).

Ligand blotting

The OMV-associated protein interacting with phage-encoded Orf96 was identified by performing ligand blot experiment. OMV proteins separated on 12% SDS-PAGE were transferred onto a polyvinylidene fluoride (PVDF) membrane and blocked with 3% BSA in TBST (Tris-Buffered Saline with Tween). The blocked membrane was then incubated at room temperature for 1 h in TBST containing 0.2% BSA and affinity-purified Orf96C6His protein (1 µg/mL). The membrane was then extensively washed with TBST, and the presence of Orf96C6His was detected by using anti-His-HRP-conjugated antibody. The protein band that gave signal was carefully excised from the reference gel, and its identity was established by performing Matrix-Assisted Laser Desorption Ionization-Time of flight (MALDI-TOF/TOF ) (60).

Reciprocal pulldown assays

Reciprocal pulldown assays were performed to ascertain interactions between OmpA and Orf96. Initially, two compatible expression plasmids were constructed to express Orf96 and OmpA with C-terminal 6XHis and FLAG sequences, respectively. The ompA gene was amplified from genomic DNA as NdeI and XhoI fragments using the primer set GD2FP/GD2RP (Table S2) and ligated in pET23b. The resulting plasmid designated as pGD2 was then used as a template and T7FP/T7RP as primers to amplify ompA gene as a BglII fragment (Table S2). The amplicon was then cloned into a broad host range mobilizable expression plasmid pRGOOD digested with BamHI. In the resulting recombinant plasmid, pGD3, the ompA gene is under the transcriptional control of the pBAD promoter and codes OmpACFLAG. The E. coli BL21 DE3 (pGD3) cells were then transformed with a second expression plasmid, pT96W, which codes Orf96C6His(18) to coexpress OmpACFLAG. The E. coli BL21 DE3 (pGD3+pT96W) cells were grown to mid-log phase, and the expression of both Orf96C6His and OmpACFLAG was induced by adding 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and 1% arabinose. Expression of both Orf96C6His and OmpACFLAG was detected by performing Western blots using either anti-His or anti-FLAG antibodies, and the clear lysate prepared from the induced cells was used to perform reciprocal pulldown assays using either Ni-NTA or anti-FLAG M2 magnetic beads following protocols optimized in our laboratory (61).

FITC labeling of OMVs

OMVs isolated from A. baumannii DS002 were labeled using FITC following the procedure described elsewhere (62). Briefly, the isolated OMVs (1 mg/mL) were diluted and mixed in 1:1 ratio with FITC stock solution prepared by dissolving in buffer containing 50 mM sodium carbonate and 100 mM sodium chloride (pH 9.2). The mixture was then incubated for 1 h at 25°C before pelleting the labeled OMVs by centrifuging the contents at 150,000×g for 90 min. The OMVs were then washed with a PBS to remove excess FITC, and the labeled OMVs were pelleted by repeating the centrifugation process. The resulting OMV pellet was resuspended in PBS and filtered through a 0.22 micron filter before examining the labeled OMVs under fluorescence spectroscopy.

In vivo imaging

The experimental mice were treated in accordance with the guidelines established by the Institutional Animal Ethics Committee (IAEC) (Proposal number:UH/IAEC/SD/2021-1/46) of School of Life Sciences, University of Hyderabad, India. Female BALB/c mice of the same age and weight were acclimatized to laboratory conditions before using them to track the mobility of intravenously injected FITC-labeled OMVs. Initially, the mice were divided into four groups, each consisting of 6-weeks-old two female BALB/c mice. One of them served as control group, and the mice of the control group were administered 200 µL solution of PBS instead of FITC-labeled OMVs. The FITC-labeled OMVs at concentrations of 5 µg, 20 µg, and 30 µg were drawn into a clean syringe and injected intravenously into the mice of three experimental groups, respectively. The mice were then sedated to minimize the movement and whole-body imaging was done at the time intervals of 4, 8, and 24 h by using an in vivo imaging system (Perkin-Elmer IVIS Spectrum). Analysis of captured images was done following procedures described elsewhere (63). Images of sedated mice were recorded using 480/520 nm excitation and emission filters to facilitate visualization of fluorescence signals within the chosen area. Initially, the acquired images and specific regions of interest (ROIs) were delineated, and the fluorescence within these ROIs was quantified using the standardized unit "Radiant Efficiency (p/s/sr)/(µW/cm2)".

OMV internalization assay

Neuronal cells (Neuro2A) cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) with 10% FBS were seeded on coverslips and incubated until reaching 70%–80% confluency. The media were replaced with fresh DMEM, and 20 µg of FITC-labeled OMVs was added for a 12-h incubation. Following incubation, cells were carefully washed with PBS, fixed using 4% paraformaldehyde, and mounted on slides. Finally, fluorescence microscopy was used to visualize and assess the internalization of FITC-labeled OMVs within the Neuro2A cells.

ACKNOWLEDGMENTS

G.D. and S.R.B. received junior research fellowships from Council of Scientific and Industrial Research (CSIR), New Delhi. D.S. is the recipient of JC Bose Fellowship from Science, Engineering Research Board (SERB), New Delhi. Research in D.S.'s laboratory was supported by SERB and Department of Biotechnology (DBT), New Delhi. School of Life Sciences received special assistance from Department of Biotechnology, Government of India under BUILDER phase-II.

SUPPLEMENTAL MATERIAL

The following material is available online at https://doi.org/10.1128/spectrum.00817-24.

10.1128/spectrum.00817-24.SuF1 Supplementary material spectrum.00817-24-s0001.docx

Tables S1 and S2.

ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.
==== Refs
REFERENCES

1 Botsios S, Manuelidis L. 2016. CJD and scrapie require agent-associated nucleic acids for infection. J Cell Biochem 117 :1947–1958. doi:10.1002/jcb.25495 26773845
2 de Villiers E-M, Gunst K, Chakraborty D, Ernst C, Bund T, Zur Hausen H. 2019. A specific class of infectious agents isolated from bovine serum and dairy products and peritumoral colon cancer tissue. Emerg Microbes Infect 8 :1205–1218. doi:10.1080/22221751.2019.1651620 31409221
3 Whitley C, Gunst K, Müller H, Funk M, Zur Hausen H, de Villiers E-M. 2014. Novel replication-competent circular DNA molecules from healthy cattle serum and milk and multiple sclerosis-affected human brain tissue. Genome Announc 2 :e00849-14. doi:10.1128/genomeA.00849-14 25169859
4 Manuelidis L. 2011. Nuclease resistant circular DNAs copurify with infectivity in scrapie and CJD. J Neurovirol 17 :131–145. doi:10.1007/s13365-010-0007-0 21165784
5 Zur Hausen H, Bund T, de Villiers E-M. 2017. Infectious agents in bovine red meat and milk and their potential role in cancer and other chronic diseases. Curr Top Microbiol Immunol 407 :83–116. doi:10.1007/82_2017_3 28349283
6 Nikitina E, Burk-Körner A, Wiesenfarth M, Alwers E, Heide D, Tessmer C, Ernst C, Krunic D, Schrotz-King P, Chang-Claude J, von Winterfeld M, Herpel E, Brobeil A, Brenner H, Heikenwalder M, Hoffmeister M, Kopp-Schneider A, Bund T. 2024. Bovine meat and milk factor protein expression in tumor-free mucosa of colorectal cancer patients coincides with macrophages and might interfere with patient survival. Mol Oncol 18 :1076–1092. doi:10.1002/1878-0261.13390 36811271
7 Bund T, Nikitina E, Chakraborty D, Ernst C, Gunst K, Boneva B, Tessmer C, Volk N, Brobeil A, Weber A, Heikenwalder M, Zur Hausen H, de Villiers E-M. 2021. Analysis of chronic inflammatory lesions of the colon for BMMF Rep antigen expression and CD68 macrophage interactions. Proc Natl Acad Sci U S A 118 :e2025830118. doi:10.1073/pnas.2025830118 33723077
8 Zur Hausen H, Bund T, de Villiers E-M. 2019. Specific nutritional infections early in life as risk factors for human colon and breast cancers several decades later. Int J Cancer 144 :1574–1583. doi:10.1002/ijc.31882 30246328
9 de Villiers E-M, Zur Hausen H. 2021. Bovine meat and milk factors (BMMFs): their proposed role in common human cancers and type 2 diabetes mellitus. Cancers (Basel) 13 :5407. doi:10.3390/cancers13215407 34771570
10 Eilebrecht S, Hotz-Wagenblatt A, Sarachaga V, Burk A, Falida K, Chakraborty D, Nikitina E, Tessmer C, Whitley C, Sauerland C, Gunst K, Grewe I, Bund T. 2018. Expression and replication of virus-like circular DNA in human cells. Sci Rep 8 :2851. doi:10.1038/s41598-018-21317-w 29434270
11 Yakkala H, Samantarrai D, Gribskov M, Siddavattam D. 2019. Comparative genome analysis reveals niche-specific genome expansion in Acinetobacter baumannii strains. PLoS One 14 :e0218204. doi:10.1371/journal.pone.0218204 31194814
12 Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5 :939–951. doi:10.1038/nrmicro1789 18007677
13 Gaynes R, Edwards JR, National Nosocomial Infections Surveillance System. 2005. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 41 :848–854. doi:10.1086/432803 16107985
14 Montefour K, Frieden J, Hurst S, Helmich C, Headley D, Martin M, Boyle DA. 2008. Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care. Crit Care Nurse 28 :15–25.18238934
15 Shamsizadeh Z, Nikaeen M, Nasr Esfahani B, Mirhoseini SH, Hatamzadeh M, Hassanzadeh A. 2017. Detection of antibiotic resistant Acinetobacter baumannii in various hospital environments: potential sources for transmission of Acinetobacter infections. Environ Health Prev Med 22 :44. doi:10.1186/s12199-017-0653-4 29165152
16 Shimose LA, Masuda E, Sfeir M, Berbel Caban A, Bueno MX, dePascale D, Spychala CN, Cleary T, Namias N, Kett DH, Doi Y, Munoz-Price LS. 2016. Carbapenem-resistant Acinetobacter baumannii: concomitant contamination of air and environmental surfaces. Infect Control Hosp Epidemiol 37 :777–781. doi:10.1017/ice.2016.69 27045768
17 Weber DJ, Anderson D, Rutala WA. 2013. The role of the surface environment in healthcare-associated infections. Curr Opin Infect Dis 26 :338–344. doi:10.1097/QCO.0b013e3283630f04 23743816
18 Longkumer T, Kamireddy S, Muthyala VR, Akbarpasha S, Pitchika GK, Kodetham G, Ayaluru M, Siddavattam D. 2013. Acinetobacter phage genome is similar to Sphinx 2.36, the circular DNA copurified with TSE infected particles. Sci Rep 3 :2240. doi:10.1038/srep02240 23867905
19 Marcet-Houben M, Gabaldón T. 2010. Acquisition of prokaryotic genes by fungal genomes. Trends Genet 26 :5–8. doi:10.1016/j.tig.2009.11.007 19969385
20 Riley DR, Sieber KB, Robinson KM, White JR, Ganesan A, Nourbakhsh S, Dunning Hotopp JC. 2013. Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples. PLoS Comput Biol 9 :e1003107. doi:10.1371/journal.pcbi.1003107 23840181
21 Dunning Hotopp JC. 2011. Horizontal gene transfer between bacteria and animals. Trends Genet 27 :157–163. doi:10.1016/j.tig.2011.01.005 21334091
22 Kesavan D, Vasudevan A, Wu L, Chen J, Su Z, Wang S, Xu H. 2020. Integrative analysis of outer membrane vesicles proteomics and whole-cell transcriptome analysis of eravacycline induced Acinetobacter baumannii strains. BMC Microbiol 20 :31. doi:10.1186/s12866-020-1722-1 32046644
23 Kulp A, Kuehn MJ. 2010. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu Rev Microbiol 64 :163–184. doi:10.1146/annurev.micro.091208.073413 20825345
24 Renelli M, Matias V, Lo RY, Beveridge TJ. 2004. DNA-containing membrane vesicles of Pseudomonas aeruginosa PAO1 and their genetic transformation potential. Microbiology (Reading) 150 :2161–2169. doi:10.1099/mic.0.26841-0 15256559
25 Lee EY, Bang JY, Park GW, Choi DS, Kang JS, Kim HJ, Park KS, Lee JO, Kim YK, Kwon KH, Kim KP, Gho YS. 2007. Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli. Proteomics 7 :3143–3153. doi:10.1002/pmic.200700196 17787032
26 Berlanda Scorza F, Doro F, Rodríguez-Ortega MJ, Stella M, Liberatori S, Taddei AR, Serino L, Gomes Moriel D, Nesta B, Fontana MR, Spagnuolo A, Pizza M, Norais N, Grandi G. 2008. Proteomics characterization of outer membrane vesicles from the extraintestinal pathogenic Escherichia coli DeltatolR IHE3034 mutant. Mol Cell Proteomics 7 :473–485. doi:10.1074/mcp.M700295-MCP200 17982123
27 Bitto NJ, Chapman R, Pidot S, Costin A, Lo C, Choi J, D’Cruze T, Reynolds EC, Dashper SG, Turnbull L, Whitchurch CB, Stinear TP, Stacey KJ, Ferrero RL. 2017. Bacterial membrane vesicles transport their DNA cargo into host cells. Sci Rep 7 :7072. doi:10.1038/s41598-017-07288-4 28765539
28 Grande R, Di Marcantonio MC, Robuffo I, Pompilio A, Celia C, Di Marzio L, Paolino D, Codagnone M, Muraro R, Stoodley P, Hall-Stoodley L, Mincione G. 2015. Helicobacter pylori ATCC 43629/NCTC 11639 outer membrane vesicles (OMVs) from biofilm and planktonic phase associated with extracellular DNA (eDNA). Front Microbiol 6 :1369. doi:10.3389/fmicb.2015.01369 26733944
29 Kim YS, Choi EJ, Lee WH, Choi SJ, Roh TY, Park J, Jee YK, Zhu Z, Koh YY, Gho YS, Kim YK. 2013. Extracellular vesicles, especially derived from Gram-negative bacteria, in indoor dust induce neutrophilic pulmonary inflammation associated with both Th1 and Th17 cell responses. Clin Exp Allergy 43 :443–454. doi:10.1111/cea.12085 23517040
30 Kolling GL, Matthews KR. 1999. Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157:H7. Appl Environ Microbiol 65 :1843–1848. doi:10.1128/AEM.65.5.1843-1848.1999 10223967
31 Stentz R, Carvalho AL, Jones EJ, Carding SR. 2018. Fantastic voyage: the journey of intestinal microbiota-derived microvesicles through the body. Biochem Soc Trans 46 :1021–1027. doi:10.1042/BST20180114 30154095
32 Schwechheimer C, Kuehn MJ. 2015. Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions. Nat Rev Microbiol 13 :605–619. doi:10.1038/nrmicro3525 26373371
33 Shoberg RJ, Thomas DD. 1993. Specific adherence of Borrelia burgdorferi extracellular vesicles to human endothelial cells in culture. Infect Immun 61 :3892–3900. doi:10.1128/iai.61.9.3892-3900.1993 8359911
34 Kuehn MJ, Kesty NC. 2005. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev 19 :2645–2655. doi:10.1101/gad.1299905 16291643
35 Ha JY, Choi SY, Lee JH, Hong SH, Lee HJ. 2020. Delivery of periodontopathogenic extracellular vesicles to brain monocytes and microglial IL-6 promotion by RNA cargo. Front Mol Biosci 7 :596366. doi:10.3389/fmolb.2020.596366 33330627
36 Palacios E, Lobos-González L, Guerrero S, Kogan MJ, Shao B, Heinecke JW, Quest AFG, Leyton L, Valenzuela-Valderrama M. 2023. Helicobacter pylori outer membrane vesicles induce astrocyte reactivity through nuclear factor-kappaappa B activation and cause neuronal damage in vivo in a murine model. J Neuroinflammation 20 :66. doi:10.1186/s12974-023-02728-7 36895046
37 Han EC, Choi SY, Lee Y, Park JW, Hong SH, Lee HJ. 2019. Extracellular RNAs in periodontopathogenic outer membrane vesicles promote TNF-alpha production in human macrophages and cross the blood-brain barrier in mice. FASEB J 33 :13412–13422. doi:10.1096/fj.201901575R 31545910
38 Bittel M, Reichert P, Sarfati I, Dressel A, Leikam S, Uderhardt S, Stolzer I, Phu TA, Ng M, Vu NK, Tenzer S, Distler U, Wirtz S, Rothhammer V, Neurath MF, Raffai RL, Günther C, Momma S. 2021. Visualizing transfer of microbial biomolecules by outer membrane vesicles in microbe-host-communication in vivo. J Extracell Vesicles 10 :e12159. doi:10.1002/jev2.12159 34664784
39 Gong T, Chen Q, Mao H, Zhang Y, Ren H, Xu M, Chen H, Yang D. 2022. Outer membrane vesicles of Porphyromonas gingivalis trigger NLRP3 inflammasome and induce neuroinflammation, tau phosphorylation, and memory dysfunction in mice. Front Cell Infect Microbiol 12 :925435. doi:10.3389/fcimb.2022.925435 36017373
40 Mi Z, Yao Q, Qi Y, Zheng J, Liu J, Liu Z, Tan H, Ma X, Zhou W, Rong P. 2023. Salmonella-mediated blood‒brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo/bacterial glioma therapy. Acta Pharm Sin B 13 :819–833. doi:10.1016/j.apsb.2022.09.016 36873179
41 Pan J, Wang Z, Huang X, Xue J, Zhang S, Guo X, Zhou S. 2023. Bacteria-derived outer-membrane vesicles hitchhike neutrophils to enhance ischemic stroke therapy. Adv Mater 35 :e2301779. doi:10.1002/adma.202301779 37358255
42 Xie J, Cools L, Van Imschoot G, Van Wonterghem E, Pauwels MJ, Vlaeminck I, De Witte C, El Andaloussi S, Wierda K, De Groef L, Haesebrouck F, Van Hoecke L, Vandenbroucke RE. 2023. Helicobacter pylori-derived outer membrane vesicles contribute to Alzheimer's disease pathogenesis via C3-C3aR signalling. J Extracell Vesicles 12 :e12306. doi:10.1002/jev2.12306 36792546
43 Dorward DW, Garon CF, Judd RC. 1989. Export and intercellular transfer of DNA via membrane blebs of Neisseria gonorrhoeae. J Bacteriol 171 :2499–2505. doi:10.1128/jb.171.5.2499-2505.1989 2496108
44 Yaron S, Kolling GL, Simon L, Matthews KR. 2000. Vesicle-mediated transfer of virulence genes from Escherichia coli O157:H7 to other enteric bacteria. Appl Environ Microbiol 66 :4414–4420. doi:10.1128/AEM.66.10.4414-4420.2000 11010892
45 Deich RA, Hoyer LC. 1982. Generation and release of DNA-binding vesicles by Haemophilus influenzae during induction and loss of competence. J Bacteriol 152 :855–864. doi:10.1128/jb.152.2.855-864.1982 6982266
46 Dhurve G, Madikonda AK, Jagannadham MV, Siddavattam D. 2022. Outer membrane vesicles of Acinetobacter baumannii DS002 are selectively enriched with TonB-dependent transporters and play a key role in iron acquisition. Microbiol Spectr 10 :e0029322. doi:10.1128/spectrum.00293-22 35266817
47 Samantarrai D, Yakkala H, Siddavattam D. 2020. Analysis of indigenous plasmid sequences of A. baumannii DS002 reveals the existence of lateral mobility and extensive genetic recombination among Acinetobacter plasmid. J Genet 99 :71.33021244
48 Yang S, Sun Y, Zhang H. 2001. The multimerization of human immunodeficiency virus type I Vif protein: a requirement for Vif function in the viral life cycle. J Biol Chem 276 :4889–4893. doi:10.1074/jbc.M004895200 11071884
49 Nonaka S, Kadowaki T, Nakanishi H. 2022. Secreted gingipains from Porphyromonas gingivalis increase permeability in human cerebral microvascular endothelial cells through intracellular degradation of tight junction proteins. Neurochem Int 154 :105282. doi:10.1016/j.neuint.2022.105282 35032577
50 Kowarsky M, Camunas-Soler J, Kertesz M, De Vlaminck I, Koh W, Pan W, Martin L, Neff NF, Okamoto J, Wong RJ, Kharbanda S, El-Sayed Y, Blumenfeld Y, Stevenson DK, Shaw GM, Wolfe ND, Quake SR. 2017. Numerous uncharacterized and highly divergent microbes which colonize humans are revealed by circulating cell-free DNA. Proc Natl Acad Sci U S A 114 :9623–9628. doi:10.1073/pnas.1707009114 28830999
51 zur Hausen H, de Villiers E-M. 2015. Dairy cattle serum and milk factors contributing to the risk of colon and breast cancers. Int J Cancer 137 :959–967. doi:10.1002/ijc.29466 25648405
52 Funk M, Gunst K, Lucansky V, Müller H, Zur Hausen H, de Villiers E-M. 2014. Isolation of protein-associated circular DNA from healthy cattle serum. Genome Announc 2 :e00846-14. doi:10.1128/genomeA.00846-14 25169856
53 Habermann D, Klempt M, Franz CMAP. 2023. Identification and characterization of novel SPHINX/BMMF-like DNA sequences isolated from non-bovine foods. Genes (Basel) 14 :1307. doi:10.3390/genes14071307 37510212
54 O’Donoghue EJ, Krachler AM. 2016. Mechanisms of outer membrane vesicle entry into host cells. Cell Microbiol 18 :1508–1517. doi:10.1111/cmi.12655 27529760
55 Juodeikis R, Carding SR. 2022. Outer membrane vesicles: biogenesis, functions, and issues. Microbiol Mol Biol Rev 86 :e0003222. doi:10.1128/mmbr.00032-22 36154136
56 Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, Nguyen M, Haditsch U, Raha D, Griffin C, et al. . 2019. Porphyromonas gingivalis in Alzheimer's disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv 5 :eaau3333. doi:10.1126/sciadv.aau3333 30746447
57 Lee KE, Kim JK, Han SK, Lee DY, Lee HJ, Yim SV, Kim DH. 2020. The extracellular vesicle of gut microbial Paenalcaligenes hominis is a risk factor for vagus nerve-mediated cognitive impairment. Microbiome 8 :107. doi:10.1186/s40168-020-00881-2 32669127
58 Emery DC, Shoemark DK, Batstone TE, Waterfall CM, Coghill JA, Cerajewska TL, Davies M, West NX, Allen SJ. 2017. 16S rRNA next generation sequencing analysis shows bacteria in Alzheimer’s post-mortem brain. Front Aging Neurosci 9 :195. doi:10.3389/fnagi.2017.00195 28676754
59 Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B. 2017. Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. Clin Microbiol Rev 30 :409–447. doi:10.1128/CMR.00058-16 27974412
60 Yergey AL, Coorssen JR, Backlund PS, Blank PS, Humphrey GA, Zimmerberg J, Campbell JM, Vestal ML. 2002. De novo sequencing of peptides using MALDI/TOF-TOF. J Am Soc Mass Spectrom 13 :784–791. doi:10.1016/S1044-0305(02)00393-8 12148803
61 Gudla R, Konduru GV, Nagarajaram HA, Siddavattam D. 2019. Organophosphate hydrolase interacts with Ton components and is targeted to the membrane only in the presence of the ExbB/ExbD complex. FEBS Lett 593 :581–593. doi:10.1002/1873-3468.13345 30791094
62 Kesty NC, Kuehn MJ. 2004. Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles. J Biol Chem 279 :2069–2076. doi:10.1074/jbc.M307628200 14578354
63 Leslie J, Robinson SM, Oakley F, Luli S. 2021. Non-invasive synchronous monitoring of neutrophil migration using whole body near-infrared fluorescence-based imaging. Sci Rep 11 :1415. doi:10.1038/s41598-021-81097-8 33446811
